Place · Level 3 · Supplement
Lutein + Zeaxanthin · Macular Pigment
AREDS2 NEJM 黄斑变性 A 级 · 10 + 2 mg/天 · 蓝光营销大量虚假 · 整食物 (深绿叶、蛋黄) 优先
Story path
Chapter 1
Macular pigment
Macular pigment
Lutein and zeaxanthin are the only two members of the carotenoid family that accumulate in the retinal macula at 1000× plasma concentrations.
Chemistry:
Carotenoids (same family as β-carotene + lycopene)Yellow / orange pigmentsPlant-derived — humans cannot synthesise them, dietary intake required
Body distribution:
Retinal macula: extremely concentrated — forms the "macular pigment (MP)"Cornea / lens: lowerBrain + skin: traceMacular pigment optical density (MPOD) can be clinically measured — inversely associated with AMD risk
Function (dual):
① Blue-light filtering: MP selectively absorbs 400-500 nm blue light → reduces retinal photo-oxidative damage
② Antioxidant: the retina has one of the body's highest metabolic rates + continuous light exposure + high PUFA membranes = extremely susceptible to oxidative damage. Lutein/Zea are the front-line antioxidants
Why this island is required on the atlas:
AREDS2 2013 JAMA — the second-most-famous nutritional RCT (after WHI); Level A evidence for AMDAge-related macular degeneration (AMD) is the leading cause of blindness in 65+ y/oChinese 65+ AMD prevalence ~ 10%, US ~ 15%"Blue-light glasses / anti-blue-light supplements" are heavily marketed; the atlas debunks themWhole foods (dark leafy greens + egg yolks) beat supplements — but supplements have value in specific populations
Chemistry:
Carotenoids (same family as β-carotene + lycopene)Yellow / orange pigmentsPlant-derived — humans cannot synthesise them, dietary intake required
Body distribution:
Retinal macula: extremely concentrated — forms the "macular pigment (MP)"Cornea / lens: lowerBrain + skin: traceMacular pigment optical density (MPOD) can be clinically measured — inversely associated with AMD risk
Function (dual):
① Blue-light filtering: MP selectively absorbs 400-500 nm blue light → reduces retinal photo-oxidative damage
② Antioxidant: the retina has one of the body's highest metabolic rates + continuous light exposure + high PUFA membranes = extremely susceptible to oxidative damage. Lutein/Zea are the front-line antioxidants
Why this island is required on the atlas:
AREDS2 2013 JAMA — the second-most-famous nutritional RCT (after WHI); Level A evidence for AMDAge-related macular degeneration (AMD) is the leading cause of blindness in 65+ y/oChinese 65+ AMD prevalence ~ 10%, US ~ 15%"Blue-light glasses / anti-blue-light supplements" are heavily marketed; the atlas debunks themWhole foods (dark leafy greens + egg yolks) beat supplements — but supplements have value in specific populations
Chapter 2
AREDS2 · AMD A-tier
AREDS2 · AMD A-tier
AREDS2 (Age-Related Eye Disease Study 2, 2013 JAMA):
Background:
AREDS1 (2001): antioxidants (vit C 500 mg + E 400 IU + Zn 80 mg + Cu 2 mg + β-carotene 15 mg) → AMD progression ↓ 25%Problem: β-carotene increases lung-cancer risk in smokers (ATBC + CARET); AREDS1 formula cannot be given to smokersAREDS2 goal: replace β-carotene + add lutein/zea + add omega-3, see if it improves
Design:
N = 4,203 early / intermediate AMD patientsMulti-arm RCT × 5 years:AREDS1 formula (with β-carotene)AREDS2 (lutein 10 mg + zea 2 mg, no β-carotene)+ omega-3 (DHA + EPA)Various combinations
Results:
Replacing β-carotene with lutein/zea: further reduces AMD progression, better safety (no β-carotene → smokers can also use it)Adding omega-3 (DHA + EPA): no significant benefit (another negative omega-3 RCT)New formula (AREDS2): vit C + E + Zn + Cu + lutein 10 mg + zea 2 mg5-year follow-up: AREDS2 vs AREDS1 AMD progression risk similar or better + improved safetySmokers: must use AREDS2 (no β-carotene)
Clinical translation:
Modern ophthalmology: intermediate-AMD patients are standardly recommended the AREDS2 formulaEarly AMD / AMD family history: discuss with ophthalmologyHealthy people without AMD: weak evidence; adequate dietary intake sufficesCataract: weak signal, not a primary indication
Hammond 2017 CARMA trial:
Healthy adults + Lutein/Zea + omega-3 × 1 yearMPOD ↑ + mild improvement in contrast sensitivity + glare recoveryNot AMD patients — a wellness signal
Bone 2007 + Stringham 2012:
Healthy adults, 12 mg Lutein/day × 6 months↑ MPOD + mild improvement in reading speed + visual processing
Background:
AREDS1 (2001): antioxidants (vit C 500 mg + E 400 IU + Zn 80 mg + Cu 2 mg + β-carotene 15 mg) → AMD progression ↓ 25%Problem: β-carotene increases lung-cancer risk in smokers (ATBC + CARET); AREDS1 formula cannot be given to smokersAREDS2 goal: replace β-carotene + add lutein/zea + add omega-3, see if it improves
Design:
N = 4,203 early / intermediate AMD patientsMulti-arm RCT × 5 years:AREDS1 formula (with β-carotene)AREDS2 (lutein 10 mg + zea 2 mg, no β-carotene)+ omega-3 (DHA + EPA)Various combinations
Results:
Replacing β-carotene with lutein/zea: further reduces AMD progression, better safety (no β-carotene → smokers can also use it)Adding omega-3 (DHA + EPA): no significant benefit (another negative omega-3 RCT)New formula (AREDS2): vit C + E + Zn + Cu + lutein 10 mg + zea 2 mg5-year follow-up: AREDS2 vs AREDS1 AMD progression risk similar or better + improved safetySmokers: must use AREDS2 (no β-carotene)
Clinical translation:
Modern ophthalmology: intermediate-AMD patients are standardly recommended the AREDS2 formulaEarly AMD / AMD family history: discuss with ophthalmologyHealthy people without AMD: weak evidence; adequate dietary intake sufficesCataract: weak signal, not a primary indication
Hammond 2017 CARMA trial:
Healthy adults + Lutein/Zea + omega-3 × 1 yearMPOD ↑ + mild improvement in contrast sensitivity + glare recoveryNot AMD patients — a wellness signal
Bone 2007 + Stringham 2012:
Healthy adults, 12 mg Lutein/day × 6 months↑ MPOD + mild improvement in reading speed + visual processing
Chapter 3
Food vs supplement
Food vs supplement
Whole-food Lutein/Zea content (mg/serving):
Kale (1 cup cooked): 25 mg — the championSpinach (1 cup cooked): 20 mgCollard greens / mustard greens / turnip greens: 10-15 mgBroccoli (1 cup cooked): 2-3 mgPeas / corn: 2-3 mgEgg yolk (1): 0.3-0.5 mg + a lipid carrier; bioavailability is very highCucumber / zucchini: 1-2 mgOranges / papaya / mango: 0.2-0.5 mg
Typical intake:
US NHANES: median 1-2 mg/day (most people well below recommendation)China (more vegetables + more eggs): average 2-3 mg/dayAREDS2 dose of 10 + 2 mg: requires 1 large cooked bowl of kale or spinach + an egg
Bioavailability:
Lutein from egg yolk: highest bioavailability — yolk lipids + phospholipids are natural carriers (Chung 2004)Cooked greens + oil (spinach sautéed with olive oil + garlic): good absorptionRaw greens (salad): moderateSupplement + fatty meal: goodSupplement + fasting: poor
Debunking "blue-light glasses + anti-blue-light supplements":
"Screen blue light causes macular damage / AMD": no RCT evidenceScreen blue-light intensity is far below natural sunlight"Anti-blue-light glasses": some evidence for reducing eye strain, but no evidence for preventing AMDReal AMD risk factors: smoking / genetics / UV / high-intensity blue light (sun, not screens) / poor nutrition + ageing"Anti-blue-light miracle formulas": mostly marketing — don't pay a premium for "screen protection"
"Dry eye / eye strain":
Lutein/Zea is not first-line for dry-eye syndrome (which is omega-3 / tear film / ambient humidity)Eye strain: brief eye exam / screen distance / 20-20-20 rule (every 20 minutes look 20 feet away for 20 seconds) outperforms supplements
Practice:
Healthy person: 1 cup of cooked greens + 1-2 eggs/day = 5-15 mg Lutein/Zea, sufficientEarly AMD / AMD family history / long-term sunlight exposure / older adults: consider AREDS2 formula (10 + 2 mg) — discuss with ophthalmologyDon't pay a premium for "anti-blue-light" marketing
Kale (1 cup cooked): 25 mg — the championSpinach (1 cup cooked): 20 mgCollard greens / mustard greens / turnip greens: 10-15 mgBroccoli (1 cup cooked): 2-3 mgPeas / corn: 2-3 mgEgg yolk (1): 0.3-0.5 mg + a lipid carrier; bioavailability is very highCucumber / zucchini: 1-2 mgOranges / papaya / mango: 0.2-0.5 mg
Typical intake:
US NHANES: median 1-2 mg/day (most people well below recommendation)China (more vegetables + more eggs): average 2-3 mg/dayAREDS2 dose of 10 + 2 mg: requires 1 large cooked bowl of kale or spinach + an egg
Bioavailability:
Lutein from egg yolk: highest bioavailability — yolk lipids + phospholipids are natural carriers (Chung 2004)Cooked greens + oil (spinach sautéed with olive oil + garlic): good absorptionRaw greens (salad): moderateSupplement + fatty meal: goodSupplement + fasting: poor
Debunking "blue-light glasses + anti-blue-light supplements":
"Screen blue light causes macular damage / AMD": no RCT evidenceScreen blue-light intensity is far below natural sunlight"Anti-blue-light glasses": some evidence for reducing eye strain, but no evidence for preventing AMDReal AMD risk factors: smoking / genetics / UV / high-intensity blue light (sun, not screens) / poor nutrition + ageing"Anti-blue-light miracle formulas": mostly marketing — don't pay a premium for "screen protection"
"Dry eye / eye strain":
Lutein/Zea is not first-line for dry-eye syndrome (which is omega-3 / tear film / ambient humidity)Eye strain: brief eye exam / screen distance / 20-20-20 rule (every 20 minutes look 20 feet away for 20 seconds) outperforms supplements
Practice:
Healthy person: 1 cup of cooked greens + 1-2 eggs/day = 5-15 mg Lutein/Zea, sufficientEarly AMD / AMD family history / long-term sunlight exposure / older adults: consider AREDS2 formula (10 + 2 mg) — discuss with ophthalmologyDon't pay a premium for "anti-blue-light" marketing
Chapter 4
Decision tree
Decision tree
Lutein/Zeaxanthin decision pathway:
Q1: What is your situation?
Healthy adult with greens / eggs in diet: food is sufficient, no supplement neededEarly / intermediate AMD: AREDS2 formula (vit C + E + Zn + Cu + lutein 10 + zea 2 mg) — under ophthalmologist guidanceAMD family history + 50+ y/o: consider prophylactic supplementation, discuss with ophthalmologyLong-term sun exposure + blue / light eyes: high AMD risk, sameCataract: no strong evidence, but supplementation acceptable
Q2: Choosing the form:
AREDS2 combination (full formula): major brands (PreserVision AREDS2, etc.) — standardSingle-ingredient lutein/zea: cheaper, but lacks the vit C + E + Zn + Cu synergyNatural source (marigold): dominant lutein source
Q3: Dose:
AREDS2 standard: 10 mg lutein + 2 mg zea/dayHigher doses (20 + 4 mg): some signal but weak evidenceMPOD testing: available at some ophthalmology clinics, assesses individual need
Q4: Take with fat:
Carotenoids must be co-ingested with fat for absorptionTake with a meal containing fatFasting absorption < 5%
Time to effect:
MPOD changes: 2-6 monthsAMD progression slowing: 1-3 years (chronic disease)"Instant sharper vision": wrong expectation — supplements do not immediately improve vision
Safety:
Very safe — food doses are extremely high (yellow skin from carotenes is pigment accumulation, not toxicity)AREDS2 dose: 5-year long-term safety data goodVery high doses (40+ mg/day): rare GI side effects
Don't buy:
"Anti-blue-light eye-care" combinations: overloaded formula + not on-target + marketing premium"Anti-myopia / lower diopter": no supplement reduces myopia (myopia is axial elongation, not pigment)"Children's eye-care gummies": mostly sugar + flavouring, low lutein content, real food is better
Connections to other atlas stories:
vitamin-a/vision L4 (complete visual chemistry)integumentary/uv-photoaging L4 (UV damage)fats-omega-3 + fish-oil (omega-3 was ineffective in AMD, review)multi-vitamin (AREDS2 is not a multivitamin replacement)
Atlas position: lutein / zeaxanthin is the key to a complete eye-health teaching on the atlas — AREDS2 is a rare nutritional RCT with high-quality long follow-up and hard endpoints, it must be covered. But whole foods first; supplements are valuable only in specific populations.
Q1: What is your situation?
Healthy adult with greens / eggs in diet: food is sufficient, no supplement neededEarly / intermediate AMD: AREDS2 formula (vit C + E + Zn + Cu + lutein 10 + zea 2 mg) — under ophthalmologist guidanceAMD family history + 50+ y/o: consider prophylactic supplementation, discuss with ophthalmologyLong-term sun exposure + blue / light eyes: high AMD risk, sameCataract: no strong evidence, but supplementation acceptable
Q2: Choosing the form:
AREDS2 combination (full formula): major brands (PreserVision AREDS2, etc.) — standardSingle-ingredient lutein/zea: cheaper, but lacks the vit C + E + Zn + Cu synergyNatural source (marigold): dominant lutein source
Q3: Dose:
AREDS2 standard: 10 mg lutein + 2 mg zea/dayHigher doses (20 + 4 mg): some signal but weak evidenceMPOD testing: available at some ophthalmology clinics, assesses individual need
Q4: Take with fat:
Carotenoids must be co-ingested with fat for absorptionTake with a meal containing fatFasting absorption < 5%
Time to effect:
MPOD changes: 2-6 monthsAMD progression slowing: 1-3 years (chronic disease)"Instant sharper vision": wrong expectation — supplements do not immediately improve vision
Safety:
Very safe — food doses are extremely high (yellow skin from carotenes is pigment accumulation, not toxicity)AREDS2 dose: 5-year long-term safety data goodVery high doses (40+ mg/day): rare GI side effects
Don't buy:
"Anti-blue-light eye-care" combinations: overloaded formula + not on-target + marketing premium"Anti-myopia / lower diopter": no supplement reduces myopia (myopia is axial elongation, not pigment)"Children's eye-care gummies": mostly sugar + flavouring, low lutein content, real food is better
Connections to other atlas stories:
vitamin-a/vision L4 (complete visual chemistry)integumentary/uv-photoaging L4 (UV damage)fats-omega-3 + fish-oil (omega-3 was ineffective in AMD, review)multi-vitamin (AREDS2 is not a multivitamin replacement)
Atlas position: lutein / zeaxanthin is the key to a complete eye-health teaching on the atlas — AREDS2 is a rare nutritional RCT with high-quality long follow-up and hard endpoints, it must be covered. But whole foods first; supplements are valuable only in specific populations.
Screen blue light + dry eye debunked
"Long screen-time → macular degeneration / blindness" is the biggest ophthalmology marketing line of the past decade — the atlas must make this clear.Real intensity of screen blue light:
Sunlight: blue light ~ 30 W/m² (clear-day outdoors)Phone screen at 30 cm: blue light ~ 0.05 W/m² (~ 600× lower than sunlight)Computer screen at 50 cm: ~ 0.02 W/m²
Conclusion: screen blue-light dose is far below natural sunlight. The "screens cause AMD" claim is not supported dosimetrically.
Real AMD risk factors:
1. Age (> 65)
2. Genetics (CFH / ARMS2)
3. Smoking (risk ↑ 2-3×)
4. White / Caucasian
5. High long-term UV exposure (outdoor work + high altitude)
6. Poor nutrition (lutein/zeaxanthin / zinc / vit C/E)
7. Cardiovascular disease + hypertension + high BMI
Screens are not in the top 10. Don't let "anti-blue-light glasses" marketing scare you.
"Digital eye strain (DES)" is real, but it is not AMD:
Mechanism: blink rate falls (12-15/min → 3-7) → dry eye; ciliary muscle sustained tension; night-time screens → delayed melatonin (atlas insomnia).
What actually works:
20-20-20 rule: every 20 minutes, look 20 feet (6 m) away for 20 secondsActive blinking + eye lubricant (preservative-free artificial tears)Screen 50-70 cm + sight line slightly downwardAdequate lighting + night-mode blue-shiftDistance viewing + outdoors (strongest evidence for childhood myopia prevention)
Truth about "anti-blue-light glasses":
Cochrane 2023 (17 RCTs, N = 619): no significant evidence of improvement in eye strain + sleep + macular degenerationSubjective benefit in some people = placeboNot harmful, but not worth the premium
Childhood myopia prevention (China 50%+ of high-schoolers):
2 hours/day outdoors = the only intervention with strong evidence (sunlight → retinal dopamine → inhibits axial elongation)It is not "less phone time," it is "more daylight"
Atlas connections: insomnia (night-time blue light delays melatonin) + circadian (light is the suprachiasmatic nucleus: The brain's master clock — set by light, it runs the body's day–night rhythm. input).